Brinckerhoff Comments on Proposed Legislation Aimed at Curbing Drug Prices
01 January 2020
Partner Courtenay Brinckerhoff was quoted in a Law360 article, “Patent Legislation To Watch In 2020,” about a slew of pending bills aimed at curbing drug prices.
Brinckerhoff said the bills that have been proposed to date appear to need work and may not have their intended effect. “I don’t necessarily think they would achieve the intended purpose and would have a lot of unintended consequences,” she said. “Once people who understand the nitty gritty details of the patent system look at them, some of those will fall apart.”
People
Related News
02 May 2024
In the News
Aaron Maguregui Assesses New Third-Party Tracking Guidance Update
Foley & Lardner LLP partner Aaron Maguregui comments on the U.S. Health and Human Services Office for Civil Rights’ (OCR) recently updated guidance on third-party tracking technology and its compliance implications
01 May 2024
In the News
Jana Kolarik on Health Care Compliance, AI
Foley & Lardner LLP partner Jana Kolarik emphasizes the importance of staying on top of recent changes in rules and enforcement priorities in the Relias Media article, "Compliance Requirements Continue to Change, Need Close Attention."
26 April 2024
In the News
IP Laterals Ngai Zhang and Drew Schulte Make Headlines with Move to Foley
Foley & Lardner LLP partners Ngai Zhang and Drew Schulte are featured across legal press for their recent move to the firm, including in the Law360 article, “Foley & Lardner Gains Two Perkins Coie IP Partners.”